Loading stock data...

Fredun Pharmaceuticals Limited

BSE: FREDUN

BSE
1,423.40 -13.65 (-0.95%)

Prev Close

1437.05

Open Price

1419.1

Volume

5,850

Today Low / High

1400 / 1447.8

52 WK Low / High

635 / 1455

Range

1,352 - 1,495

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1423.4, reflecting a change of -13.65 (-0.94986%). The expected target range on the BSE is 1,352 - 1,495. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

08 Oct 1,419.10 0.30%
07 Oct 1,448.00 -0.76%
06 Oct 1,399.00 0.61%
03 Oct 1,326.00 5.14%
01 Oct 1,346.00 -1.25%
30 Sep 1,344.00 -2.18%
29 Sep 1,288.00 1.67%
26 Sep 1,355.00 -3.58%
25 Sep 1,263.40 2.24%
24 Sep 1,239.70 1.91%
23 Sep 1,216.75 0.97%
22 Sep 1,171.70 3.84%
19 Sep 1,264.10 -2.79%
18 Sep 1,275.00 -2.41%
17 Sep 1,248.30 0.06%
16 Sep 1,202.40 3.82%
15 Sep 1,220.95 -1.34%
12 Sep 1,268.00 -4.42%
11 Sep 1,269.90 -2.89%
10 Sep 1,227.00 2.01%

Fredun Pharmaceuticals Limited Graph

Fredun Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Fredun Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,423.40, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,423.40 1,437.63 1,293.87 - 1,581.40
1,451.87 1,161.49 - 1,742.24
1,466.10 1,026.27 - 1,905.93
Bearish Scenario 1,423.40 1,409.17 1,268.25 - 1,550.08
1,394.93 1,115.95 - 1,673.92
1,380.70 966.49 - 1,794.91

Overview of Fredun Pharmaceuticals Limited

ISIN

INE194R01017

Industry

Medical - Pharmaceuticals

Vol.Avg

19,256

Market Cap

6,720,813,691

Last Dividend

0.7

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of FREDUN

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-23 September 23, 25 0.7 0.7 2025-09-23 2025-10-30
2024-09-23 September 23, 24 0.7 0.7 2024-09-23 2024-10-30
2023-09-22 September 22, 23 0.7 0.7 2023-09-22 2023-10-29
2022-09-14 September 14, 22 0.7 0.7 2022-09-15 2022-10-30
2021-09-16 September 16, 21 0.7 0.7 2021-09-18 2021-10-27

Stock Rating Details for FREDUN

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 1 Strong Sell
ROE Score 4 Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 451.71 Cr 347.59 Cr 104.12 Cr 0.2305 4.98 Cr 0.19 Cr 47.42 Cr 19.74 Cr 42.53 54.91 Cr 0.0437
2024-03-31 346.58 Cr 275.68 Cr 70.89 Cr 0.2045 1.34 Cr 5.30 Cr 34.38 Cr 15.62 Cr 33.66 37.77 Cr 0.0451
2023-03-31 274.34 Cr 218.27 Cr 56.07 Cr 0.2044 0.01 Cr 3.27 Cr 24.99 Cr 10.81 Cr 24.13 27.93 Cr 0.0394
2022-03-31 221.74 Cr 184.26 Cr 37.48 Cr 0.1690 0.87 Cr 2.12 Cr 11.73 Cr 6.34 Cr 15.26 15.43 Cr 0.0286
2021-03-31 131.48 Cr 107.02 Cr 24.46 Cr 0.1861 0.03 Cr 1.66 Cr 7.51 Cr 2.01 Cr 5.05 9.26 Cr 0.0153

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.64 Cr 487.41 Cr 346.03 Cr 141.3827 Cr 167.15 Cr 166.51 Cr 239.89 Cr 52.49 Cr 0.00 Cr 0.00 Cr 1.24 Cr 321.1771 Cr
2024-03-31 1.07 Cr 307.60 Cr 186.13 Cr 121.4712 Cr 105.51 Cr 104.44 Cr 175.00 Cr 46.15 Cr 0.00 Cr 0.00 Cr 0.47 Cr 166.8275 Cr
2023-03-31 2.95 Cr 257.28 Cr 160.90 Cr 96.3757 Cr 86.55 Cr 83.60 Cr 150.12 Cr 38.63 Cr 0.00 Cr 0.00 Cr 0.00 Cr 139.6567 Cr
2022-03-31 1.94 Cr 186.99 Cr 118.93 Cr 68.0606 Cr 60.66 Cr 58.72 Cr 46.46 Cr 32.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 73.7504 Cr
2021-03-31 0.99 Cr 161.62 Cr 118.55 Cr 43.0702 Cr 39.64 Cr 38.65 Cr 67.57 Cr 30.32 Cr 0.00 Cr 0.00 Cr 0.00 Cr 86.4558 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -29.0629 Cr -6.3542 Cr 39.1159 Cr -35.1691 Cr 3.6988 Cr 5.2231 Cr -6.1062 Cr 20.0303 Cr 61.6367 Cr 0.0000 Cr -64.8909 Cr
2024-03-31 -0.4387 Cr -7.6391 Cr 5.9930 Cr -8.0778 Cr -2.0849 Cr 1.3502 Cr -7.6391 Cr 15.6234 Cr 18.9634 Cr 0.0000 Cr -24.8743 Cr
2023-03-31 -14.4088 Cr -9.4045 Cr 25.1767 Cr -23.9034 Cr 1.3633 Cr 3.4351 Cr -9.4946 Cr 10.8066 Cr 34.0668 Cr 0.0000 Cr -103.6635 Cr
2022-03-31 -2.3802 Cr -4.1430 Cr 7.4668 Cr -6.6662 Cr 0.9436 Cr 2.0718 Cr -4.2860 Cr 6.3353 Cr 13.1251 Cr 0.0000 Cr 21.1144 Cr
2021-03-31 0.1699 Cr -1.3879 Cr -0.7130 Cr -1.2180 Cr -1.9309 Cr 1.1282 Cr -1.3879 Cr 2.0147 Cr 4.7442 Cr 0.0000 Cr -17.1129 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 119.40 Cr 88.06 Cr 31.34 Cr 0.2625 15.57 Cr 6.77 Cr 14.33 16.99 Cr 0.0567
2025-03-31 165.44 Cr 128.37 Cr 37.07 Cr 0.2241 12.96 Cr 6.00 Cr 12.71 17.25 Cr 0.0363
2024-12-31 101.84 Cr 77.65 Cr 24.20 Cr 0.2376 12.14 Cr 5.33 Cr 11.29 13.23 Cr 0.0524
2024-09-30 106.89 Cr 80.74 Cr 26.15 Cr 0.2446 12.43 Cr 4.27 Cr 9.05 13.95 Cr 0.0400
2024-06-30 78.81 Cr 64.98 Cr 13.83 Cr 0.1755 9.43 Cr 4.13 Cr 8.79 10.48 Cr 0.0524

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 5.97 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -141.38 Cr
2025-03-31 0.64 Cr 5.29 Cr 7.18 Cr 177.59 Cr 239.89 Cr 427.95 Cr 52.49 Cr 487.41 Cr 346.03 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -130.87 Cr
2024-09-30 0.14 Cr 10.27 Cr 10.41 Cr 116.14 Cr 175.85 Cr 302.64 Cr 47.69 Cr 355.42 Cr 224.55 Cr
2024-06-30 -2.16 Cr 4.32 Cr 2.16 Cr 0.00 Cr 0.00 Cr 2.16 Cr 0.00 Cr 0.00 Cr -121.47 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 6.77 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 6.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 5.33 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 4.27 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 4.13 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.35 Cr 1.35 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹763.10 ₹91,376,415,181.00 ₹234,880.00

Key Executives

Executive Chairman & Joint MD
Dr. Daulat N. Medhora

Gender: Not Specified

Year Born: 1945

MD, Chief Financial Officer & Whole Time Director
Mr. Fredun Nariman Medhora

Gender: male

Year Born: 1986

FAQs about Fredun Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Daulat N. Medhora.

What is the current market price of the stock?

The current price is ₹1,423.40.

What is the 52-week price range?

The range is ₹635-1455.

What is the market capitalization of the company?

The market capitalization is ₹672.08 crores.

What is the dividend yield?

The dividend yield is 0.05%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 30.04.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Fredun Pharmaceuticals Limited (ISIN: INE194R01017) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹672.08 crores and an average daily volume of 19,256 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.7.